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Background: The purpose of this study was to test the hypothesis that dog plasma concentrations of selected
nutrients decrease after undergoing caloric restriction for weight loss. Thirty-one overweight dogs that had
successfully lost at least 15% of initial body weight were included in the study. Nutrients that had been previously
identified to be at potential risk of deficiency during caloric restriction were measured in plasma (choline, amino
acids) and urine (selenium) at the initiation and completion of a standardized weight loss regimen in dogs.
Results: Dogs remained healthy throughout the study, and no signs attributable to nutrient deficiency were noted.
Percentage weight loss was 28.3% (16.0-40.1%) starting body weight, over a period of 250 days (91–674 days). Median
energy intake during the weight loss period was 62 (44 to 74) Kcal/kg0.75 target weight per day. Choline (P = 0.046) and
threonine (P = 0.02) decreased after weight loss. Glycine (P = 0.041), and urinary selenium:creatinine ratio (P = 0.006) both
increased after weight loss. There were no other significant differences in plasma nutrient concentrations.
Conclusions: Since concentrations of most measured nutrients did not change significantly, the data are not consistent
with widespread nutrient deficiency in dogs undergoing caloric restriction using a diet formulated for weight loss.
However, the significance of the decrease in plasma choline concentration requires further assessment.
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Obesity is one of the most common health problems of
dogs, with between 34-59% of the canine population in
the United States and Europe currently overweight or
obese [1,2]. The condition is associated with numerous
diseases and a shorter lifespan [3-5]. With growing aware-
ness of the consequences of obesity, weight loss plans
may become more common in veterinary medicine.
Various strategies can be used for weight loss, but most
require caloric restriction, adjusted for each individual,
and consideration must be given to choice of diet. Starting
points for caloric restriction can vary from resting energy
requirement (RER; 70 kcal/kg0.75) for current weight, to
RER for ideal weight, to a percentage of the maintenance
energy requirement (MER) for current or ideal weight
[6-8]. However, adjustments are commonly required, dur-
ing the course of the regimen, in order to achieve a rate of
weight loss which is safe, maximises owner compliance,* Correspondence: ajgerman@liv.ac.uk
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reproduction in any medium, provided the orand minimises loss of lean body mass. The exact level of
restriction required can vary considerably (50-82% of
maintenance energy requirement at target weight) and
overweight dogs with low energy requirements may re-
quire considerable caloric restriction [9].
Given that most dogs and cats are fed commercial
complete and balanced pet foods, the intake of all nutri-
ents in the diet is decreased when calories are restricted.
Thus, it is possible that intake of some nutrients might
be suboptimal during weight loss, particularly in animals
with low energy requirements that require significant
caloric restriction to achieve successful weight loss. Al-
though recommendations for optimal macronutrient
composition can vary [10-12], an increased nutrient:cal-
orie ratio compared to maintenance foods is common in
most foods formulated for weight loss to account for this
caloric restriction. However, optimal nutrient density and
levels of various nutrients of concern have not yet been
determined. A recent in silico study highlighted the poten-
tial for nutrient deficiencies when using a range of diets at
current levels of energy restriction [13]. However, argu-
ably, in vivo studies are a better way of determining theLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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portant to aid in the formulation of optimal nutrient pro-
files for weight loss diets.
The nutrient status of an animal can be measured in
various ways, including tissue biopsy (e.g. liver biopsy
for copper, muscle biopsy for taurine), measurement of
the nutrient in either plasma or urine, and using proxy
measures of nutritional adequacy (e.g. urinary methyl-
malonic acid for cobalamin status, erythrocyte glutathi-
one peroxidase measurement for selenium status) [14].
Measurement of plasma nutrient concentrations, have
long been used to determine nutrient status in many
mammalian species. For humans, plasma amino acid
measurement has been used to evaluate protein-calorie
malnutrition (PCM) in third world countries [15] whilst,
in cats, it was plasma measurement of taurine that
helped to identify taurine deficiency in cats [16]. In the
field of animal nutrition, plasma nutrient measurements
have been used extensively to determine both whether
and which essential amino acid is limiting in a diet
[17-19]. In dogs, one of the first uses of plasma nutrient
measurement was more than 50 years ago, when the
rate-limiting amino acid for growth was determined in
dogs using plasma amino acid concentrations in dogs
eating various dietary proteins [20]. More recently,
plasma taurine, cysteine, and methionine have also been
used to assess canine dietary completeness [21]. There-
fore, although not perfect, such methods have the ad-
vantage that the samples can be acquired non-invasively.
As a result, the current study used urinary and plasma
nutrient measurements to determine if the status of
selected nutrients changes in dogs undergoing caloric
restriction for weight loss.
Methods
Ethics statement
The study protocol adhered to the University of Liverpool
Animal Ethics Guidelines, and was approved by the
University of Liverpool Research Ethics Committee.
Owners of all participating animals gave informed
written consent.
Study design
This was a non-randomised observational study assessing
changes in circulating nutrient concentrations in a cohort
of dogs with naturally-occurring obesity, and has been re-
ported according to the Strengthening and Reporting of
Observational Studies in Epidemiology statement guide-
lines [22].
Animals
Dogs were referred to the Royal Canin Weight Manage-
ment Clinic, University of Liverpool, UK, for investigation
and management of obesity and associated disorders.Thirty-one dogs were recruited between February 2005
and August 2010, and those successfully losing weight had
completed by January 2011. Eligibility criteria included
confirmation of obesity (based upon body fat measurement
by dual-energy X-ray absorptiometry; DEXA), required
loss of at least 15% of starting body weight, and availability
of sufficient surplus plasma and urine for analysis.
Weight loss regimen
Full details of the weight loss regimen have been previ-
ously described [9,23]. Briefly, dogs were determined to be
systemically well, and without significant abnormalities on
complete blood count, serum biochemical analysis and
urinalysis. Throughout weight loss, patients were weighed
on electronic weigh scales (Soehnle Professional), which
were regularly calibrated using test weights (Blake and
Boughton Ltd.). Body composition was analysed by fan-
beam DEXA (Lunar Prodigy Advance; GE Lunar), and re-
sults were used to estimate target weight [23]. Pre-weight
loss total body composition results were used to estimate
target weight [9,24]. Further, by comparing pre- and post-
weight loss DEXA scan results, change in fat and lean
mass could be estimated [9,25].
A weight management protocol was then initiated [9,23],
using a high protein high fibre weight loss diet (Table 1),
and fed according to manufacturer’s instructions. The ini-
tial food allocation for weight loss was determined by first
estimating maintenance energy requirement (MER= 440 kJ
[105 Kcal] × body weight [kg]0.75/day) [26] using the esti-
mated target weight. The exact level of restriction for each
dog was then individualised based upon gender and other
factors (i.e. presence of associated diseases such as osteo-
arthritis and other orthopaedic disorders), and was typically
between 50-60% of MER at target weight [23]. Owners also
implemented lifestyle and activity alterations to assist in
weight loss. Dogs were reweighed every 7–21 days and
changes were made to the dietary plan if necessary [9,23].
In dogs that successfully reached target weight, detailed
evaluation was conducted after the weight loss. At this
stage, body weight was recorded, and body composition
assessed by DEXA. The detailed re-evaluation assessment
was not conducted in dogs failing to complete, either be-
cause they were euthanased (for unrelated reasons) before
reaching target weight or were lost to follow-up.
Laboratory analyses
All blood and urine samples were taken after a fast of at
least 16 h, from each dog, both before initiating the
weight loss programme and when target weight was suc-
cessfully achieved. A complete blood count was per-
formed using whole blood from EDTA tubes. Serum was
analysed for a biochemistry profile and thyroid (T4) con-
centrations. Immediately after collection, heparinized
samples were centrifuged, and the plasma was harvested.
Table 1 Average analysis of the diet used for weight loss
in the study dogs
Nutrient Per Mcal Per 100 g as fed
Kcal/kg Metabolizable Energy 2900* —
Crude protein (g) 104.0 30.2
Arginine (g) 5.4 1.6
Histidine (g) 2.0 0.6
Isoleucine (g) 3.8 1.1
Met and Cys (g) 3.6 1.0
Leucine (g) 7.7 2.2
Lysine (g) 4.1 1.2
Phe and Tyr (g) 9.6 2.8
Threonine (g) 3.3 1.0
Tryptophan (g) 0.9 0.3
Valine (g) 4.4 1.3
Total fat (g) 33.0 9.6
Linoleic acid (g) 7.3 2.1
Calcium (g) 3.1 0.9
Phosphorus (g) 2.4 0.7
Magnesium (g) 0.17 0.05
Sodium (g) 1.0 0.3
Potassium (g) 2.8 0.8
Chloride (g) 3.0 0.9
Iron (mg) 57.0 17.0
Copper (mg) 6.9 2.0
Zinc (mg) 69.0 20.0
Manganese (mg) 24.0 6.9
Selenium (mg) 0.05 0.01
Iodine (mg) 1.0 0.3
Vitamin A (IU) 6990 2001
Vitamin D3 (IU) 242 70
Vitamin E (IU) 276 80
Thiamin (mg) 9.0 2.6
Riboflavin (mg) 18.0 5.2
Pyridoxine (mg) 8.0 2.3
Niacin (mg) 56.0 16.2
Pantothenic acid (mg) 16.0 4.6
Cobalamin (mg) 0.06 0.02
Folic acid (mg) 1.5 0.4
Choline (mg) 860 249
*All nutrients listed on an energy basis.
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at −20°C until analysis, within 30 min of sample collec-
tion. Samples remained frozen until they were shipped on
dry ice to the laboratories chosen for analyte measure-
ment (see below).Choline and betaine metabolite measurements
Plasma concentrations of free choline and betaine, were
quantified, by the Caudill Laboratory, Cornell University,
USA, using liquid chromatography-tandem mass spec-
trometry according to methods of Holm and Wang
[27,28] with modifications based on the instrumentation
[29]. The intra- and inter-assay precision (coefficient of
variation) of the method is <3%, based on in-house con-
trol materials.
Plasma amino acid assessment
Amino acids were analyzed with a commercial amino
acid analyserg by the Amino Acid Laboratory, University
of California Davis, USA. Methionine was not measured
because previous studies have demonstrated that this
amino acid is susceptible to oxidation during storage
[30]. Cysteine was also not measured because this amino
acid is susceptible to breakdown if not treated with sul-
fosalicylic acid immediately after sampling [31].
Urinary selenium assessment
Urinary selenium measurements were made by the Food
and Environmental Research Agency, York, UK. Aliquots
(1 mL) of test sample plus certified reference materials
were digested in nitric acid using quartz high pressure
closed vessels and microwave heating. The digests were
diluted with water containing propan-2-ol and internal
standard (Rhodium standard, “Aristar” grade, 1000 ppm.
VWR International Ltd.), prior to quantification by in-
ductively coupled plasma-mass spectrometry, using colli-
sion cell run in hydrogen mode (7500ce ICPMS, Agilient
Technologies). Reagent blanks and samples spiked with a
known amount of each analyte were analysed with the test
samples for recovery estimate purposes. Urinary selenium
concentrations were adjusted for urinary creatinine excre-
tion, measured by an automated biochemistry analyser
(Kone Specific Supra biochemistry analyzer; Thermo
Fisher Scientific, Inc.) and results were expressed as a ra-
tio of selenium to creatinine.
Data analysis
Data are expressed as median (range) except where indi-
cated. Statistical analyses were performed with computer
software (Stats Direct version 2.6.8, Stats Direct Ltd.),
with the level of significance set at P < 0.05 for two-sided
analyses. Given that there were no known previous stud-
ies examining changes in nutrient biomarkers in obese
dogs undergoing weight loss, a meaningful power calcu-
lation was not possible. Instead, the number of dogs en-
rolled was based upon the prior experience from
previous studies of plasma biomarkers from the same
clinic [25,32,33].
The Shapiro-Wilk test was first used to assess all data
sets, and parametric and non-parametric tests were used
Table 2 Summary of weight loss in the study dogs
Criterion Result
Age (months) 66 (12 to 132)
Sex 17 NM, 2 F, 12 NF
Breed Akita, Border Collie, Cairn Terrier, CKCS (3),
Cocker Spaniel, Corgi, Dachshund, Doberman,
English Bull Terrier, Golden Retriever, Irish Setter,
Labrador (10), Lhasa Apso, Miniature Schnauzer,
Mixed Breed (5), Pug (3), Samoyed,
Schipperke, Yorkshire Terrier (2)
Body weight PRE (kg) 30.6 (5.4 to 77.0)
Body weight POST (kg) 23.2 (4.4 to 51.4)
Body fat mass PRE (g) 11400 (1600 to 37700); 45% (30 to 55)
Body fat mass POST (g) 6300 (700 to 15600); 28% (11 to 45)
Lean tissue mass PRE (g) 13800 (3600 to 36600); 52% (43 to 68)
Lean tissue mass POST (g) 13300 (3300 to 33400); 68% (53 to 86)
Duration (days) 250 (91 to 674)
Rate of weight loss1(%/week) 0.8 (0.3 to 1.4)
Body weight change2 (%) −28.3 (−16.0 to −40.1)
Change in fat mass2 (%) −53 (−78 to −18)
Change in lean mass2 (%) −7 (−36 to 10)
EI during weight loss3 (units) 259 (184 to 310) [62 (44 to 74)]
All data are expressed as median (range). M: male; NM: neutered male; F: female;
NF: neutered female; CKCS: cavalier king Charles spaniel. 1Rate of weight loss
expressed as percentage of starting body weight lost per week. 2Refers to the
percentage change in starting mass calculated as follows: ([start mass–
end mass] ÷ start mass) × 100%. 3EI: energy intake expressed as metabolizable
energy (in kJ [kcal]) per kg of metabolic body weight (BW0.75) per day.
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gression analysis, the signed ranks test, the Mann–Whitney
U test, and Kendall’s rank correlation.
Differences in either plasma nutrient concentrations,
clinical biochemistry parameters, or urine selenium:cre-
atinine ratio prior to and after weight loss, were assessed
with the Wilcoxon signed ranks test, and associations
between changes in plasma analytes and clinical bioche-
mistry parameters were assessed with Kendall’s rank cor-
relation. Where significant differences were identified,
linear regression was then used to determine factors that
were associated. The outcome variable of interest was per-
centage change in the respective nutrient (i.e. {[nutrient]
PRE–[nutrient]POST} ÷ [nutrient]PRE × 100), while factors
tested included signalment factors (e.g. age at enrolment,
sex, breed group [retriever vs. not retriever]), baseline pa-
rameters (e.g. percentage body fat pre-weight-loss, starting
body weight, lean tissue mass pre-weight loss [in kg]), and
weight loss outcomes (duration of weight loss, percentage
weight loss, energy intake during weight loss, percentage
change in body fat mass, and percentage change in lean
tissue mass). Percentage change in fat mass was calcu-
lated using the following formula: (fat mass [kg]PRE–
fat mass [kg] POST) ÷ fat mass [kg]PRE × 100 ); similarly,
percentage change in fat mass was calculated using the fol-
lowing formula: (lean mass [kg]PRE–lean mass [kg] POST) ÷
lean mass [kg]PRE × 100). Initially, simple linear regression
was used. A multiple linear regression model was then
constructed, which initially included any variables identi-
fied as P < 0.2 on univariable analysis. The model was sub-
sequently refined by backwards-stepwise elimination of
the least significant variable at each round, and variables
were retained in the final model if they were significant
(P < 0.05), or where removal lead to a notable reduction
(e.g. ≥30%) in the overall fit of the model.
Results
Dogs and outcome of weight loss
During the period of recruitment, (February 2005 to Au-
gust 2010), 140 new cases were referred to the clinic; of
these dogs, 79 dogs completed their weight loss program
by June 2011, 4 were successfully losing weight but had
not completed by June 2011, 7 dogs had died or been
euthanased (for unrelated reasons) and the weight loss
program had been discontinued in the remaining 40
dogs (either due to owner-related reasons including
illness and bereavement, or because the owner chose to
stop). Of the 79 dogs successfully reaching target, 31 were
ultimately identified that had lost >15% body weight and
had sufficient plasma and urine available for all assays to
be conducted. During shipment, the tubes containing
plasma samples from 5 of the 31 dogs were damaged and,
as a result, only 26 dogs had plasma amino acids and cho-
line performed. Paired sampled from 20 dogs were availablefor urine selenium analysis. Those 20 samples were selected
from the original 31 dogs in order of percentage weight lost
(i.e., the 20 dogs with the greatest percentage of weight loss
had their samples analysed). Weight loss characteristics for
dogs included in the study did not differ from those also
completing but not ultimately being included in the study
(data not shown).
In the 31 dogs finally included in the study, percentage
weight loss was 28.3% (16.0-40.1%) starting body weight
(SBW), over a period of 250 days (91–674 days); there-
fore, median rate of weight loss was 0.8% (0.3-1.4%)
SBW/week (Table 2). Neither the signalment nor weight
loss outcomes differed between the 26 dogs having cho-
line and amino acid analysis, and those where it was not
measured (P > 0.12 for all; data not shown); similarly,
signalment and weight loss outcomes did not differ be-
tween the 20 dogs where urinary selenium was measured
and those where it was not measured (P > 0.28 for all,
data not shown).
Changes in clinical biochemistry before and after
weight loss
Clinical biochemistry results are shown in Table 3. Urea
was greater after weight loss (P = 0.047), whilst albumin
(P < 0.001), cholesterol (P = 0.040), globulins (P = 0.012),



















73 (32–383), 7, 0 56 (26–400), 3, 0 0-150 0.065
Albumin (g/L) 31 (27–36), 1, 0 29 (26–34), 0, 0 23-35 <0.001
Cholesterol
(mmol/L)
5.6 (2.5-9.1), 6, 1 5.0 (1.9-7.7), 4, 2 3.5-7.0 0.040
Creatinine
(μmol/L)
84 (37–123), 1, 0 80 (30–122), 1, 0 20-110 0.033
Globulins
(g/L)
31 (21–48), 1, 0 27 (22–41), 0, 0 22-40 0.012
Glucose
(mmol/L)
5.3 (3.5-8.7), 8, 0 5.2 (3.0-7.4), 6, 0 3.5-5.5 0.210
Urea (mmol/L) 4.6 (1.6-8.0), 2, 3 5.6 (3.5-8.9), 3, 0 3.5-7.0 0.047
Triglycerides
(mmol/L)
1.2 (0.6-5.3), 8, 0 0.9 (0.6-2.1), 3, 0 0.6-1.5 0.015
Data are expressed as median (range), number above reference range, and
number below reference range. P values quoted for Wilcoxon signed ranks test.
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However, there was no difference in alanine aminotrans-
ferase (P = 0.893), alkaline phosphatase (P = 0.065), and
creatinine (P = 0.064) and glucose (P = 0.210).
Changes in plasma nutrient concentrations with
weight loss
Plasma nutrient concentrations are shown in Table 4. For
the 26 dogs with initial and post sample analysis of cho-
line, betaine, and amino acids, the median time between
the two samples (weight loss program duration) was
242 days, with a range of 91–674 days. Plasma amino acid
concentrations had wide ranges and no systematic change
was noted across all nutrients (i.e. some increased while
other decreased with weight loss). Additionally, median
concentrations of the amino acid were not outside the ref-
erence range of the laboratory (determined by two stand-
ard deviations from their median score in 131 healthy
animals), with the exception of aspartic acid and glutamic
acid, which were more than the reference range before
and after weight loss.
Plasma concentrations of choline (P = 0.046) and threo-
nine (P = 0.02) both decreased with weight loss. In con-
trast, plasma glycine concentration (P = 0.045) and urinary
selenium:creatinine ratio (P = 0.006) both increased. There
were no significant changes for any of the other plasma
nutrient concentrations. Further, none of changes observed
were associated with alterations in clinical biochemistry
parameters (Kendall’s tau −0.15 to 0.28, P > 0.1 for all),
and there was no association between changes incholine and betaine concentrations before and after
weight loss (Kendall’s tau −0.18, P = 0.203).
Associations between weight loss outcomes and changes
in plasma nutrient concentration
Simple and multiple linear regression analyses were used
to determine factors associated with the significant
changes in nutrients identified. For changes in plasma
choline concentration, simple linear regression identified
possible associations (at P < 0.2) for breed group, starting
body fat percentage, starting lean tissue mass, and rate of
weight loss (Table 5). However, two models, with equally
good fit were identified (Table 6). For model 1, starting
lean tissue mass (i.e. greater starting lean mass, greater de-
crease in plasma choline concentration; r = −0.47, r2 =
0.22, P = 0.02) and duration of weight loss (i.e. longer dur-
ation of weight loss, greater decrease in plasma choline
concentration; r = 0.35, r2 = 0.12, P = 0.08) were retained
in the model. For model, 2 starting lean tissue mass was
again included (i.e. greater starting lean mass, greater de-
crease in plasma choline concentration; r = −0.45, r2 =
0.20, P = 0.02), but instead with rate of weight loss (i.e.
slower rate of weight loss, greater decrease in plasma cho-
line concentration; r = 0.35, r2 = 0.12, P = 0.08; Table 3).
This was because there was a strong negative association
between duration of weight loss and rate of weight loss
(Kendall’s tau −0.67, P < 0.001).
For plasma glycine concentration, simple linear regres-
sion identified an association with breed group (i.e. greater
gain in glycine concentration in non-retriever breeds;
r = −0.40, r2 = 0.16, P = 0.045) only. However, none of the
factors tested were found to be significantly associated
with plasma threonine concentration, or urinary selen-
ium:creatinine ratio (P > 0.1 for all, full data not shown).
Discussion
In the current study, changes in plasma or urinary nutri-
ents have been assessed before and after a controlled
weight loss plan. Changes in plasma and urinary status nu-
trient status are the result of a combination of factors in-
cluding the requirement of the individual dog for that
nutrient, the level of inclusion in the diet, and daily food
consumption. If a diet is used to induce safe weight loss in
obese dogs, nutrients are included at increased amounts
relative to the energy content of the diet, to minimise the
risk of a deficiency occurring when energy intake is re-
stricted [34]. Therefore, the extent to which the process of
formulation is successful is reflected in changes in nutrient
status, or lack thereof. A widespread decline in nutrient sta-
tus was not seen although plasma or urinary concentra-
tions of certain nutrients, most notably choline, did decline
significantly. This suggests that choline requirements might
increase during caloric restriction, especially in larger dogs
(i.e. with a greater lean body mass) and those dogs
Table 4 Median (and range) of selected nutrients in dogs pre and post weight loss
Nutrient Mean ± SEM* Before weight loss After weight loss P value
Choline (umol/L) - 68.8 (34.1-287.8) 57.5 (22.9-129.9) 0.046
Betaine (umol/L) - 94.8 (54.2-251.6) 83.0 (44.1-153.4) 0.79
Urinary selenium (umol/L) - 1886 (51–7317) 2633 (430–4634) 0.31
Urinary Selenium:creatinine - 0.10 (0.03-0.20) 0.14 (0.07-0.24) 0.006
Taurine (nmol/ml) 77 ± 2.1 99.7 (63.5-232.1) 109.9 (71.0-345.6) 0.19
Aspartic Acid (nmol/ml) 7 ± 0.2 14.0 (0.9-27.7) 12.5 (3.6-90.6) 0.73
Threonine (nmol/ml) 178 ± 5.0 211.4 (89.6-359.2) 184.5 (85.5-324.6) 0.02
Serine (nmol/ml) 107 ± 2.6 110.0 (72.8-168.1) 111.6 (71.0-151.7) 0.64
Asparagine (nmol/ml) 40 ± 1.1 37.3 (0.0-63.9) 39.0 (17.6-111.9) 0.68
Glutamic Acid (nmol/ml) 23 ± 1.2 154.2 (75.9-303.5) 117.4 (25.2-219.8) 0.07
Glutimine (nmol/ml) - 485.4 (43.7-855.2) 452.3 (170.8-650.7) 0.27
Glycine (nmol/ml) 268 ± 8.4 188.6 (101.3-304.9) 204.7 (125.6-290.7) 0.045
Alanine (nmol/ml) 388 ± 9.6 373.3 (144.2-783.3) 384.8 (225.8-743.2) 0.99
Citrulline (nmol/ml) 41 ± 1.9 47.2 (0.0-159.3) 40.6 (0.0-99.9) 0.08
Amino-Butyric Acid (nmol/ml) - 21.9 (0.0-64.6) 21.7 (5.0-53.3) 0.53
Valine (nmol/ml) 157 ± 4.1 186.0 (130.2-275.3) 188.2 (122.9-261.8) 0.52
Cystathione (nmol/ml) - 3.2 (0.0-11.6) 3.8 (1.1-11.0) 0.64
Isoleucine (nmol/ml) 51 ± 1.3 67.0 (40.1-96.0) 65.3 (38.0-111.4) 0.23
Leucine (nmol/ml) 120 ± 3.2 122.6 (22.6-207.1) 124.8 (62.4-210.3) 0.62
Tyrosine (nmol/ml) 39 ± 1.1 38.9 (4.0-71.7) 38.7 (10.6-58.0) 0.49
Phenylalanine (nmol/ml) 45 ± 0.9 59.0 (5.6-91.6) 54.2 (20.9-89.6) 0.29
Ornithine (nmol/ml) 35 ± 1.5 15.3 (1.8-34.4) 14.5 (1.2-26.5) 0.22
Lysine (nmol/ml) 132 ± 5.0 117.7 (11.4-415.8) 93.4 (7.7-251.3) 0.14
1-Methyl-Histidine (nmol/ml) - 6.2 (0.0-27.0) 6.7 (0.0-40.6) 0.82
Histidine (nmol/ml) 71 ± 1.6 57.8 (3.5-95.4) 59.0 (10.4-90.4) 0.45
Tryptophan (nmol/ml) 60 ±1.7 62.2 (28.7-115.3) 53.2 (19.9-100.0) 0.06
3-Methyl-Histidine (nmol/ml) - 10.5 (4.0-15.9) 9.4 (4.8-19.5) 0.40
Carnosine (nmol/ml) - 29.7 (12.3-49.5) 24.2 (11.5-51.6) 0.09
Arginine (nmol/ml) 102 ± 2.6 79.5 (25.8-265.8) 80.9 (15.6-130.0) 0.11
Hydroxyproline (nmol/ml) 67 ± 4.1 22.5 (1.1-52.1) 22.0 (0.0-103.7) 0.24
Proline (nmol/ml) 246 ± 8.2 140.0 (80.4-234.0) 123.6 (85.3-327.6) 0.79
* References ranges taken from Delaney et al., 2003 [21].
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changes included a decrease in plasma threonine concen-
tration, and increases in plasma glycine concentration and
urinary selenium:creatinine ratio. Therefore, although the
results should be considered in light of the limitations of
the study, the status of certain nutrients should be care-
fully reviewed in dogs during caloric restriction. All dogs
in the current study were given the same purpose-
formulated weight loss diet and, as a result, the findings
cannot necessarily be generalized to other diets used for
weight management. Therefore, additional studies are
now warranted, assessing a wider range of diets fed at
different levels of caloric energy intake. Further, the
risks of deficiency are likely to be greater if a dietformulated for maintenance were used instead of a
purpose-formulated weight loss diet, where the nutrient
content is supplemented relative to energy content.
The dogs remained healthy during their period of weight
loss, and did not demonstrate any signs of deficiency. A
minority (<5%) of plasma biochemical parameters were
outside the reference ranges both before and after weight
loss. This is consistent with what would be expected by
chance since reference intervals are typically established
to include ~95% of the normal canine population [35].
Further, although some biochemical parameters changed
during weight loss (either increasing or decreasing), the
majority of results remained within the reference interval.
Indeed, these findings are the same as those that have
Table 5 Simple linear regression to determine factors





Age [months] 0.2 0.26 0.07 0.204
Sex 10.8 0.18 0.03 0.364
Neuter status 14.5 0.13 0.02 0.518
Breed group* −23.8 −0.40 0.16 0.043
Starting weight [kg] −1.0 −0.57 0.32 0.002
Body fat percentage (pre) [%] −2.3 −0.48 0.23 0.014
Lean tissue mass (pre) [kg] −1.9 −0.54 0.29 0.004
Duration of weight loss [days] −0.09 −0.46 0.21 0.018
Rate of weight loss [%SBW/week] 42.4 0.48 0.23 0.013
Percentage weight loss [%] 0.1 0.03 0.00 0.873
Energy intake during weight loss −0.6 −0.14 0.02 0.493
Change in fat tissue mass [%] −0.5 −0.19 0.04 0.345
Change in lean tissue mass [%] −0.02 0.00 0.00 0.979
* Breed based upon a dummy variable where dogs of retriever breeds were
assigned a value of 1.
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that such changes are not of clinical significance. Further-
more, the changes in these biochemical parameters are
unlikely to be associated with the observed changes in nu-
trient status because there was no significant association
between them.
With the exception of threonine and glycine, there were
no significant changes in any plasma concentrations of es-
sential and non-essential amino acids in this study. Since
each amino acid has a unique role in the body, and par-
ticular pathways for synthesis and degradation, there may
be various reasons for this. Firstly, the diet used for weight
loss was supplemented in protein relative to its energy
content and, thus, able to meet minimum requirements
even during a period of caloric restriction. Further, al-
though the plasma concentration of threonine decreased
during weight loss, concentrations for all dogs remainedTable 6 Multiple linear regression to determine factors
associated with changes in percentage plasma
choline concentration
Model 1 Regression coefficient r r2 P
Final model 0.62 0.33 0.004
Lean tissue mass (pre) [kg] −1.5 −0.47 0.22 0.019
Duration −0.06 −0.35 0.12 0.082
Model 2 Regression coefficient r r2 P
Final model 0.62 0.33 0.004
Lean tissue mass (pre) [kg] −1.5 −0.45 0.20 0.025
Rate of weight loss 28.4 0.35 0.12 0.082within the laboratory’s reference range, no signs of de-
ficiency were seen in any dog, and the changes did not
correlate with lean tissue loss during weight loss. This
suggests that a clinical deficiency was unlikely. In contrast,
plasma glycine concentration increased with weight loss
although, once again, all concentrations remained within
the laboratory’s reference range.
Previous studies have indicated that methionine is sus-
ceptible to oxidation during storage [30], whilst cysteine is
unstable in storage if samples are not deproteinised by
treating with sulphosalicylic acid immediately after sam-
pling [31]. Given that the storage conditions of the
current study were not optimized for either amino acid,
we were concerned that results would not be reliable and,
therefore, chose not to analyse them. This is a potential
limitation, not least in light of a previous in silico study
suggesting that both might be at risk of deficiency during
caloric restriction [13]. As a result, a further study should
be considered to assess these nutrients in dogs undergo-
ing caloric restriction, using samples that have been ap-
propriately prepared and analysed. Unexpectedly, median
concentrations of glutamic acid and aspartic acid were
greater than the laboratory range in many dogs, and the
reasons for this are again not known. An issue with sam-
ple storage or subsequent assay is possible, and further as-
sessment should now be considered.
Selenium is a mineral involved in antioxidant pathways
and thyroid function, and is important for immune system
function [26]. Selenium status is tightly regulated in dogs,
and many different methods of assessment have been sug-
gested, including measurement of plasma selenium, blood
selenium, selenoproteins, erythrocyte glutathione peroxid-
ase, urinary selenium and liver selenium [14,36]. The lack
of a single ‘gold-standard’ assay method highlights the dif-
ficulty in accurate assessment of selenium status in dogs.
In the current study, increased urinary selenium excretion
was noted after the period of dietary restriction, which is
notable in light of previous work demonstrating that urin-
ary selenium excretion does not vary greatly with different
diets [36]. The reasons for this finding are not known.
First, urine selenium:creatinine ratio was used as a proxy
measure, for 24-hour urinary excretion, and this ratio has
been validated against 24 h selenium excretion in humans
[37]. Whilst this measure has not been validated in dogs,
urinary ratios based upon creatinine are widely accepted
for measurement of other substances such as protein [38]
and cortisol [39]. Second, only 20 pairs of urine samples
were tested, and these might not have been representative.
Against this, however, was the fact that there were no dif-
ferences in either baseline parameters or weight loss out-
comes in the dogs where urinary selenium was measured,
compared with those not tested. Third, it is possible
that, despite caloric restriction, selenium intake on the
weight loss diet was greater than on the baseline diets.
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tained accurate records of food intake prior to weight
loss, making it difficult to determine if this was, indeed,
the case. Given it was not possible to assess selenium
status with additional methods, such as erythrocyte
glutathione peroxidase or measurement of selenopro-
teins [14], these results should be interpreted cautiously
and need confirmation in future studies.
Whatever the reason, these findings refute concerns
highlighted in a recent in silico study that suggested selen-
ium intake might be deficient when fed using the same
weight loss diet at the predicted levels of caloric restric-
tion [13]. This might be due to the fact that the calcula-
tions in the previous study were based upon dietary
requirements recommended by the NRC [26], but the ac-
tual selenium requirements of adult dogs are not known,
partly due to the difficulty in accurate assessment of sel-
enium status in animals. Further, it is possible that re-
quirements decrease during a period of underfeeding, as
would be encountered on a weight loss program. Ad-
ditional studies that can better assess selenium status in
relation to healthy dogs are now warranted, for example
by measuring blood and liver selenium concentrations in
dogs undergoing different degrees of caloric restriction.
Choline is a vitamin-like substance that has multiple
roles in the body, including neurotransmission, hepatic
lipid transport and storage, coagulation, and as a methyl
donor as a part of phosphatidylcholine [26]. Amongst
five diets analysed in a previous in silico study [13], cho-
line was the second most likely nutrient to be at risk of
deficiency during caloric restriction. All dogs in the
current study received a diet containing of 860 mg cho-
line per 1000 kcal metabolisable energy and, fed at this
concentration, intake might be less than NRC recom-
mended allowance. For instance, the daily choline intake
of an obese dog with a target weight of 23.2 kg, receiving
a daily energy intake of 62 kcal/kg0.75 (the median en-
ergy intake during weight loss for the current study),
would be 563 mg, which is 95% of the recommended
daily choline allowance (592.0 mg/day) [26]. The NRC
recommended allowances (RA) are not minimum re-
quirements (MR), or ‘the minimal concentration of a
maximally bioavailable nutrient that will support a de-
fined physiological state’ [26], and intake less than RA
will not necessarily lead to a deficiency state. During the
NRC review, when the MR of a particular nutrient was
known, the NRC RA was estimated, for instance being
based upon adequate intake (AI) or ‘the concentration
of nutrient demonstrated to support a defined physio-
logical state, when no MR has been demonstrated’ [26].
Not surprisingly given the way it is determined, AI is usu-
ally greater than MR. In the case of choline, the current
RA was based on AI data from studies conducted over
50 years ago [26]. In light of this, the significance of thedecrease in plasma choline concentration seen in the
current study is not known.
For the changes in choline status to be of significance,
clinical signs of choline deficiency would be expected. In
dogs, choline deficiency has been associated with hypo-
cholesterolaemia, vomiting, fatty liver disease, and death
[14]. However, all dogs remained clinically well through-
out the study and did not demonstrate any of these
signs, or any signs that might be associated with liver
disease (e.g. icterus). Further, there were no changes in
liver enzyme activity and, although, serum cholesterol
decreased, none of the dogs had concentrations less than
the reference range after weight loss. Thus, it is unlikely
that the changes in choline status were clinically rele-
vant. One additional factor we considered as a cause of
the observed changes in choline was plasma betaine sta-
tus. Choline is metabolised to betaine, by the sequential
action of choline dehydrogenase and betaine aldehyde
dehydrogenase [40]. However, the fact that there were
no changes in plasma betaine with weight loss, and no
association with changes in plasma choline concentra-
tions, suggests that this was not the reasons for the dif-
ferences observed in the current study.
As with selenium, there is a lack of published informa-
tion on choline status in dogs and, in particular, methods
of determining deficiency. In a previous study [41] total
choline and phospholipid-containing choline concentra-
tions were measured using the protozoa Torulopsis pinto-
lopessi, a method was previously described in rats and
man [42]. Their results were reported in μl/mL and, when
converted to μmol/L, the median choline concentration
was 4128 μmol/L (range: 2255–7678) in normal dogs.
These results are different from those of the current study
both before (median 68.8 μmol/L; range: 34.1-287.8) and
after (57.5 μmol/L: range: 22.9-129.9) weight loss. How-
ever, more technologically advanced methods were used
in the current study, including mass spectrometry, which
is the gold standard method in human medicine [27]. This
difference in methodology, and the previous study includ-
ing not only choline, but also all phospholipid-containing
choline, could explain the difference in results. Given this
difference, further studies using similar methodology are
warranted to determine choline status in healthy dogs.
Signs of choline deficiency in dogs, cats and humans can
include weight loss, hepatic lipidosis, anorexia, vomiting,
neurological signs, disorders, and coagulopathies [26,43].
However, even though plasma choline concentration de-
creased during weight loss in the current study, the dogs
were regularly re-evaluated throughout their period of
weight loss, did not display any clinical signs consistent
with choline deficiency. That said, the possibility of a sub-
clinical choline deficiency cannot be excluded. However, it
is also possible that either endogenous choline production
or dietary intake of other nutrients might alter or lessen
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crease during periods of energy restriction. In diet formu-
lation, choline is relatively easy nutrient to supplement,
and there are minimal toxicity concerns. For this reason,
further studies assessing benefit of supplementation of
choline during weight loss programs are warranted.
A number of limitations should be considered when
interpreting the results of the current study. First, we
chose to study a group of client-owned dogs with
naturally-occurring obesity, and this group was diverse in
terms of the diet fed before weight loss, environment and
housing, and signalment. The degree of excess adiposity
also varied, as did the caloric restriction required to
achieve weight loss, and the rate of weight loss achieved.
Further, as mentioned above, due to ethical limitations we
were not able to include a control group, for instance, a
population of obese dogs undergoing weight loss using a
standard maintenance diet. Ethical limitations were also
the reason why plasma and urine nutrient measurement
was chosen, instead of tissue biopsy for instance, as the
principle means of assessing nutrient status. Whilst such
a group would have undoubtedly strengthened our find-
ings, use of such a group would not be allowed in a clin-
ical study involving pet dogs and, instead, laboratory dogs
would have had to be used. However, the advantage of
using client-owned animals, with naturally occurring
obesity, was the fact that the findings are representative of
the true clinical picture. Furthermore, measuring at two
time points, enabled dogs to act as their own controls, ef-
fectively controlling for many individual differences,
namely baseline parameters and environment. A second
limitation was the fact that dogs were on a variety of diets
prior to starting the weight loss program, and exact details
(i.e., products used and amounts fed) were lacking. Thus,
the differences identified before and after weight loss
might instead reflect differences in dietary composition
rather than being the result of caloric restriction, per se.
A third limitation was the fact that it was not possible
to conduct all nutrient analyses for all dogs. In this re-
spect, selenium analyses were only conducted on urine
samples from a subset of the study dogs, whilst five
plasma samples were lost when their tubes were damaged
in transit. Although this might have influenced the results
obtained, these subsets were broadly similar to the main
study population. Given that fewer sample pairs were
tested than was planned, study power is likely to be less
than anticipated for these measurements. However, the
fact that differences in both plasma choline and urinary
selenium were identified, suggests that the study findings
were not materially affected. Also, on the issue of study
power, a fourth limitation was the fact that, since a study
of this nature had not been performed previously, it was
not possible to perform a meaningful a priori power cal-
culation. Given that differences before and after weightloss were not identified for many nutrients, it is possible
that some statistical comparisons were underpowered.
Nonetheless, if necessary, the results of the current study
can now be used to determine study numbers required
for a future study.
A final study limitation was the fact that, whilst owners
were instructed to feed the weight loss diet exclusively,
some owners still gave their dogs additional food, in the
form of treats and table scraps. Although these extra food-
stuffs make a minor contribution to overall intake, on
average 1% of MER [11], these may nonetheless, have had
an impact on results. Unfortunately, such foods were not
recorded accurately in the current study.
Conclusions
The current study has suggested that plasma or urinary
concentrations for many nutrients do not change appre-
ciably when obese dogs undergo a weight loss program.
The main exceptions were decreases in plasma choline
and threonine concentrations, and increases in plasma
glycine concentration and urinary selenium:creatinine
ratio. The reason for these changes are not fully clear
and results should be considered in light of the limita-
tions of the study. Nonetheless, the significant decrease
in plasma choline concentration during weight loss
might suggest increased choline requirements during
weight loss. Despite this decrease, no signs of choline
deficiency were noted during the weight loss program,
suggesting that clinical consequences did not occur, al-
though subclinical nutrient deficiency cannot be ex-
cluded entirely. Further studies are now warranted to
assess a wider range of diets, fed at different levels of
caloric restriction.
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